|
Volumn 95, Issue 3, 2011, Pages 270-272
|
Seizure control: A secondary benefit of chemotherapeutic temozolomide in brain cancer patients
|
Author keywords
Antiepileptic drugs; Brain tumor; Chemotherapy; Seizure; Temozolomide
|
Indexed keywords
ETIRACETAM;
OXCARBAZEPINE;
TEMOZOLOMIDE;
VALPROIC ACID;
ZONISAMIDE;
ADULT;
ARTICLE;
ASTROCYTOMA;
BRAIN CANCER;
BRAIN SURGERY;
CANCER GRADING;
CASE REPORT;
DISEASE ASSOCIATION;
DISEASE CONTROL;
DOSE RESPONSE;
DRUG RESPONSE;
ELECTROENCEPHALOGRAM;
EVENING DOSAGE;
FEMALE;
GLIOMA;
HUMAN;
INTRACTABLE EPILEPSY;
LOW DRUG DOSE;
MORNING DOSAGE;
MULTIPLE CYCLE TREATMENT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
TUMOR VOLUME;
ADULT;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ASTROCYTOMA;
BRAIN NEOPLASMS;
DACARBAZINE;
ELECTROENCEPHALOGRAPHY;
FEMALE;
HUMANS;
SEIZURES;
|
EID: 79960359625
PISSN: 09201211
EISSN: 18726844
Source Type: Journal
DOI: 10.1016/j.eplepsyres.2011.03.018 Document Type: Article |
Times cited : (14)
|
References (7)
|